An engineered A549 cell line expressing CD13 and TMPRSS2 is permissive to clinical isolate of human coronavirus 229E
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved..
The lack of suitable in vitro culture model has hampered research on wild-type (WT) human coronaviruses. While 3D tissue or organ cultures have been instrumental for this purpose, such models are challenging, time-consuming, expensive and require extensive cell culture adaptation and directed evolution. Consequently, high-throughput applications are beyond reach in most cases. Here we developed a robust A549 cell line permissive to a human coronavirus 229E (HCoV-229E) clinical isolate by transducing CD13 and transmembrane serine protease 2 (TMPRSS2), henceforth referred to as A549++ cells. This modification allowed for productive infection, and a more detailed analysis showed that the virus might use the TMPRSS2-dependent pathway but can still bypass this pathway using cathepsin-mediated endocytosis. Overall, our data showed that A549++ cells are permissive to HCoV-229E clinical isolate, and applicable for further studies on HCoV-229E infectiology. Moreover, this line constitutes a uniform platform for studies on multiple members of the Coronaviridae family.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:588 |
---|---|
Enthalten in: |
Virology - 588(2023) vom: 01. Nov., Seite 109889 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lie, Laurensius Kevin [VerfasserIn] |
---|
Links: |
---|
Themen: |
229E |
---|
Anmerkungen: |
Date Completed 13.11.2023 Date Revised 13.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.virol.2023.109889 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362739404 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362739404 | ||
003 | DE-627 | ||
005 | 20231226091853.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.virol.2023.109889 |2 doi | |
028 | 5 | 2 | |a pubmed24n1209.xml |
035 | |a (DE-627)NLM362739404 | ||
035 | |a (NLM)37778059 | ||
035 | |a (PII)S0042-6822(23)00208-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lie, Laurensius Kevin |e verfasserin |4 aut | |
245 | 1 | 3 | |a An engineered A549 cell line expressing CD13 and TMPRSS2 is permissive to clinical isolate of human coronavirus 229E |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.11.2023 | ||
500 | |a Date Revised 13.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a The lack of suitable in vitro culture model has hampered research on wild-type (WT) human coronaviruses. While 3D tissue or organ cultures have been instrumental for this purpose, such models are challenging, time-consuming, expensive and require extensive cell culture adaptation and directed evolution. Consequently, high-throughput applications are beyond reach in most cases. Here we developed a robust A549 cell line permissive to a human coronavirus 229E (HCoV-229E) clinical isolate by transducing CD13 and transmembrane serine protease 2 (TMPRSS2), henceforth referred to as A549++ cells. This modification allowed for productive infection, and a more detailed analysis showed that the virus might use the TMPRSS2-dependent pathway but can still bypass this pathway using cathepsin-mediated endocytosis. Overall, our data showed that A549++ cells are permissive to HCoV-229E clinical isolate, and applicable for further studies on HCoV-229E infectiology. Moreover, this line constitutes a uniform platform for studies on multiple members of the Coronaviridae family | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a 229E | |
650 | 4 | |a A549 | |
650 | 4 | |a CD13 | |
650 | 4 | |a Human coronavirus | |
650 | 4 | |a Lentiviral transduction | |
650 | 4 | |a TMPRSS2 | |
650 | 7 | |a Cathepsins |2 NLM | |
650 | 7 | |a EC 3.4.- |2 NLM | |
650 | 7 | |a TMPRSS2 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.21.- |2 NLM | |
650 | 7 | |a Serine Endopeptidases |2 NLM | |
650 | 7 | |a EC 3.4.21.- |2 NLM | |
700 | 1 | |a Synowiec, Aleksandra |e verfasserin |4 aut | |
700 | 1 | |a Mazur, Jedrzej |e verfasserin |4 aut | |
700 | 1 | |a Rabalski, Lukasz |e verfasserin |4 aut | |
700 | 1 | |a Pyrć, Krzysztof |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Virology |d 1955 |g 588(2023) vom: 01. Nov., Seite 109889 |w (DE-627)NLM000011347 |x 1096-0341 |7 nnns |
773 | 1 | 8 | |g volume:588 |g year:2023 |g day:01 |g month:11 |g pages:109889 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.virol.2023.109889 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 588 |j 2023 |b 01 |c 11 |h 109889 |